A Surge of Biologics for Severe Asthma - Managed Healthcare Executive


6/21/2022 12:00:00 AM2 years 10 months ago
by Rosanna Sutherby, Pharm.D.

Six biologics on the market and more are in the pipeline. Biologics target the inflammatory cytokines involved in the pathogenesis of asthma.

Asthma is a chronic respiratory disease that causes narrowing and inflammation of the airways that compromises breathing and, in some cases, can be fatal. Symptoms include coughing, wheezing, shortne… [+7603 chars]

full article...